Access the full text.
Sign up today, get DeepDyve free for 14 days.
S. Muthian, D. Rademacher, Craig Roelke, Garrett Gross, Cecilia Hillard (2004)
Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemiaNeuroscience, 129
C. Weber, A. Schober, A. Zernecke (2004)
Chemokines: Key Regulators of Mononuclear Cell Recruitment in Atherosclerotic Vascular DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 24
M. Rajesh, P. Mukhopadhyay, S. Batkai, G. Haskó, L. Liaudet, J. Huffman, A. Csiszar, Z. Ungvari, K. Mackie, S. Chatterjee, P. Pacher (2007)
CB2-receptor stimulation attenuates TNF-alpha-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion.American journal of physiology. Heart and circulatory physiology, 293 4
V. Mendizábal, E. Adler‐Graschinsky (2007)
Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusionsBritish Journal of Pharmacology, 151
Nichola Underdown, C. Hiley, W. Ford (2005)
Anandamide reduces infarct size in rat isolated hearts subjected to ischaemia–reperfusion by a novel cannabinoid mechanismBritish Journal of Pharmacology, 146
T. Klein (2005)
Cannabinoid-based drugs as anti-inflammatory therapeuticsNature Reviews Immunology, 5
S. Ylä-Herttuala, B. Lipton, M. Rosenfeld, T. Särkioja, T. Yoshimura, E. Leonard, J. Witztum, D. Steinberg (1991)
Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions.Proceedings of the National Academy of Sciences of the United States of America, 88
C. Murray, Alan Lopez (1997)
Mortality by cause for eight regions of the world: Global Burden of Disease StudyThe Lancet, 349
I. Galve-Roperh, T. Aguado, J. Palazuelos, M. Guzmán (2007)
The Endocannabinoid System and Neurogenesis in Health and DiseaseThe Neuroscientist, 13
B. Nieswandt, Barsom Aktas, A. Moers, U. Sachs (2005)
Platelets in atherothrombosis: lessons from mouse modelsJournal of Thrombosis and Haemostasis, 3
F. Mauler, E. Horváth, J. Vry, Rainer Jäger, T. Schwarz, S. Sandmann, C. Weinz, R. Heinig, M. Böttcher (2006)
BAY 38-7271: a novel highly selective and highly potent cannabinoid receptor agonist for the treatment of traumatic brain injury.CNS drug reviews, 9 4
J. Ashton, Rosanna Rahman, S. Nair, B. Sutherland, M. Glass, I. Appleton (2007)
Cerebral hypoxia-ischemia and middle cerebral artery occlusion induce expression of the cannabinoid CB2 receptor in the brainNeuroscience Letters, 412
P. Libby, M. Aikawa (2003)
Stabilization of atherosclerotic plaques: New mechanisms and clinical targetsNature Medicine, 9
(2003)
ischemia? J Neurochem.2004;88:1159–1167
C. Filippo, F. Rossi, S. Rossi, M. D'Amico (2004)
Cannabinoid CB2 receptor activation reduces mouse myocardial ischemia‐reperfusion injury: involvement of cytokine/chemokines and PMNJournal of Leukocyte Biology, 75
J. Despres, A. Golay, L. Sjöström (2005)
Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia.The New England journal of medicine, 353 20
Hansson Hansson (2005)
Inflammation, atherosclerosis, and coronary artery diseaseN Engl J Med, 352
J. Wagner, K. Varga, E. Ellis, B. Rzigalinski, B. Martin, G. Kunos (1997)
Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shockNature, 390
P. Pacher, S. Batkai, G. Kunos (2006)
The Endocannabinoid System as an Emerging Target of PharmacotherapyPharmacological Reviews, 58
R. Leker, E. Shohami, O. Abramsky, H. Ovadia (1999)
Dexanabinol; a novel neuroprotective drug in experimental focal cerebral ischemiaJournal of the Neurological Sciences, 162
G. Lavie, A. Teichner, E. Shohami, H. Ovadia, R. Leker (2001)
Long term cerebroprotective effects of dexanabinol in a model of focal cerebral ischemiaBrain Research, 901
Sharmistha Ghosh, Anju Preet, J. Groopman, R. Ganju (2006)
Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes.Molecular immunology, 43 14
X. Yu, S. Dluz, D. Graves, L. Zhang, H. Antoniades, W. Hollander, S. Prusty, A. Valente, C. Schwartz, G. Sonenshein (1992)
Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates.Proceedings of the National Academy of Sciences of the United States of America, 89 15
M. Rajesh, P. Mukhopadhyay, S. Batkai, G. Haskó, Lucas Liaudet, V. Drel, I. Obrosova, P. Pacher (2007)
Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption.American journal of physiology. Heart and circulatory physiology, 293 1
(2004)
PMC free article
R. Levy, A. Schurr, I. Nathan, A. Dvilanski, A. Livne (1976)
Impairment of ADP-Induced Platelet Aggregation by Hashish ComponentsThrombosis and Haemostasis, 36
M. Mittleman, Rebecca Lewis, M. Maclure, J. Sherwood, J. Muller (2001)
Triggering Myocardial Infarction by MarijuanaCirculation: Journal of the American Heart Association, 103
K. Varga, J. Wagner, D. Bridgen, G. Kunos (1998)
Platelet‐ and macrophage‐derived endogenous cannabinoids are involved in endotoxin‐induced hypotensionThe FASEB Journal, 12
R. Mathew, W. Wilson, D. Humphreys, J. Lowe, K. Wiethe (1992)
Middle cerebral artery velocity during upright posture after marijuana smokingActa Psychiatrica Scandinavica, 86
A. Krylatov, Ugdyzhekova Ds, N. Bernatskaya, Maslov Ln, R. Mekhoulam, R. Pertwee, G. Stephano (2001)
Activation of Type II Cannabinoid Receptors Improves Myocardial Tolerance to Arrhythmogenic Effects of Coronary Occlusion and ReperfusionBulletin of Experimental Biology and Medicine, 131
X. Ni, E. Geller, M. Eppihimer, T. Eisenstein, M. Adler, R. Tuma (2004)
Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte/endothelial interactions in an experimental autoimmune encephalomyelitis modelMultiple Sclerosis, 10
D. Panikashvili, R. Mechoulam, S. Beni, A. Alexandrovich, E. Shohami (2005)
CB1 cannabinoid receptors are involved in neuroprotection via NF-κB inhibitionJournal of Cerebral Blood Flow & Metabolism, 25
K. Hayakawa, K. Mishima, M. Nozako, M. Hazekawa, Y. Aoyama, Ayumi Ogata, Kazuhiko Harada, Masayuki Fujioka, K. Abe, N. Egashira, K. Iwasaki, M. Fujiwara (2007)
High-cholesterol feeding aggravates cerebral infarction via decreasing the CB1 receptorNeuroscience Letters, 414
A. Newby (2005)
Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture.Physiological reviews, 85 1
E. Deusch, H. Kress, B. Kraft, S. Kozek‐Langenecker (2004)
The Procoagulatory Effects of Delta-9-Tetrahydrocannabinol in Human PlateletsAnesthesia & Analgesia, 99
M. Kowalska, M. Ratajczak, Marcin Majka, Jianguo Jin, S. Kunapuli, Lawrence Brass, M. Poncz (2000)
Stromal cell-derived factor-1 and macrophage-derived chemokine: 2 chemokines that activate platelets.Blood, 96 1
J. Silber, G. Barber (1995)
Doxorubicin-induced cardiotoxicity.The New England journal of medicine, 333 20
L. Hollister (1986)
Health aspects of cannabis.Pharmacological reviews, 38 1
Eli Gelfand, C. Cannon (2006)
Rimonabant: a cannabinoid receptor type 1 blocker for management of multiple cardiometabolic risk factors.Journal of the American College of Cardiology, 47 10
P. Pacher, S. Batkai, G. Kunos (2005)
Blood pressure regulation by endocannabinoids and their receptorsNeuropharmacology, 48
V. Braunersreuther, F. Mach (2006)
Leukocyte recruitment in atherosclerosis: Potential targets for therapeutic approaches?Cellular and Molecular Life Sciences CMLS, 63
Lusis Lusis (2000)
AtherosclerosisNature, 407
B. Osterud, E. Bjørklid (2003)
Role of monocytes in atherogenesis.Physiological reviews, 83 4
S. Sidney (2002)
Cardiovascular Consequences of Marijuana UseThe Journal of Clinical Pharmacology, 42
A. Sinor, S. Irvin, D. Greenberg (2000)
Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in ratsNeuroscience Letters, 278
S. Steffens, N. Veillard, C. Arnaud, G. Pelli, F. Burger, C. Staub, A. Zimmer, J. Frossard, F. Mach (2005)
Low dose oral cannabinoid therapy reduces progression of atherosclerosis in miceNature, 434
S. Parmentier-Batteur, K. Jin, X. Mao, Lin Xie, D. Greenberg (2002)
Increased Severity of Stroke in CB1 Cannabinoid Receptor Knock-Out MiceThe Journal of Neuroscience, 22
R. Leker, N. Gai, R. Mechoulam, H. Ovadia (2003)
Drug-Induced Hypothermia Reduces Ischemic Damage: Effects of the Cannabinoid HU-210Stroke: Journal of the American Heart Association, 34
W. Dewey (1986)
Cannabinoid pharmacology.Pharmacological reviews, 38 2
C. Lagneux, D. Lamontagne (2001)
Involvement of cannabinoids in the cardioprotection induced by lipopolysaccharideBritish Journal of Pharmacology, 132
C. Lunn, Jay Fine, A. Rojas-Triana, James Jackson, Xuedong Fan, Ted Kung, W. Gonsiorek, Martin Schwarz, Brian Lavey, Joseph Kozlowski, Satwant Narula, Daniel Lundell, R. Hipkin, L. Bober (2006)
A Novel Cannabinoid Peripheral Cannabinoid Receptor-Selective Inverse Agonist Blocks Leukocyte Recruitment in VivoJournal of Pharmacology and Experimental Therapeutics, 316
C. Kanakis, M. Pouget, K. Rosen (1979)
Lack of cardiovascular effects of delta-9-tetrahydrocannabinol in chemically denervated men.Annals of internal medicine, 91 4
M. Karsak, E. Gaffal, Rahul Date, Lihua Wang-Eckhardt, J. Rehnelt, S. Petrosino, K. Starowicz, Regina Steuder, E. Schlicker, B. Cravatt, R. Mechoulam, R. Buettner, S. Werner, V. Marzo, T. Tüting, A. Zimmer (2007)
Attenuation of Allergic Contact Dermatitis Through the Endocannabinoid SystemScience, 316
L. Gaal, A. Rissanen, A. Scheen, O. Ziegler, S. Rössner (2005)
Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe studyThe Lancet, 365
B. Julien, P. Grenard, F. Teixeira-Clerc, J. Nhieu, Liying Li, M. Karsak, A. Zimmer, A. Mallat, S. Lotersztajn (2005)
Antifibrogenic role of the cannabinoid receptor CB2 in the liver.Gastroenterology, 128 3
S. Batkai, Z. Járai, J. Wagner, S. Goparaju, K. Varga, Jie Liu, Lei Wang, F. Mirshahi, A. Khanolkar, A. Makriyannis, R. Urbaschek, N. Garcia, A. Sanyal, G. Kunos (2001)
Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosisNature Medicine, 7
T. Aguado, E. Romero, K. Monory, J. Palazuelos, M. Sendtner, G. Marsicano, B. Lutz, M. Guzmán, I. Galve-Roperh (2007)
The CB1 Cannabinoid Receptor Mediates Excitotoxicity-induced Neural Progenitor Proliferation and Neurogenesis*Journal of Biological Chemistry, 282
S. Batkai, M. Rajesh, P. Mukhopadhyay, G. Haskó, L. Liaudet, B. Cravatt, A. Csiszar, Z. Ungvari, P. Pacher (2007)
Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase.American journal of physiology. Heart and circulatory physiology, 293 2
P. Sacerdote, C. Martucci, A. Vaccani, F. Bariselli, A. Panerai, A. Colombo, D. Parolaro, P. Massi (2005)
The nonpsychoactive component of marijuana cannabidiol modulates chemotaxis and IL-10 and IL-12 production of murine macrophages both in vivo and in vitroJournal of Neuroimmunology, 159
M. Rajesh, H. Pan, P. Mukhopadhyay, S. Batkai, D. Osei-Hyiaman, G. Haskó, L. Liaudet, B. Gao, P. Pacher (2007)
Pivotal Advance: Cannabinoid‐2 receptor agonist HU‐308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosisJournal of Leukocyte Biology, 82
Maslov Ln, O. Lasukova, A. Krylatov, L. Hanuš, R. Pertwee, I. Ivanchuk, D. Crowford (2006)
Role of cannabinoid receptors in the regulation of cardiac contractility during ischemia/reperfusionBulletin of Experimental Biology and Medicine, 142
Gawaz Gawaz, Langer Langer, May May (2005)
Platelets in inflammation and atherogenesisJ Clin Invest, 115
K. Maresz, G. Pryce, G. Pryce, E. Ponomarev, G. Marsicano, J. Croxford, L. Shriver, C. Ledent, Xiaodong Cheng, E. Carrier, Monica Mann, Gavin Giovannoni, Gavin Giovannoni, R. Pertwee, T. Yamamura, N. Buckley, C. Hillard, B. Lutz, David Baker, David Baker, B. Dittel (2007)
Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cellsNature Medicine, 13
P. Pacher, S. Batkai, D. Osei-Hyiaman, László Offertáler, Jie Liu, J. Harvey‐White, A. Brassai, Z. Járai, B. Cravatt, G. Kunos (2005)
Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase.American journal of physiology. Heart and circulatory physiology, 289 2
P. Libby (2002)
Inflammation in atherosclerosisNature, 420
Yin Wang, Yan Liu, Yasuhiko Ito, T. Hashiguchi, Isao Kitajima, M. Yamakuchi, Hideaki Shimizu, Seiichi Matsuo, Hitoshi Imaizumi, Ikuro Maruyama (2001)
Simultaneous measurement of anandamide and 2-arachidonoylglycerol by polymyxin B-selective adsorption and subsequent high-performance liquid chromatography analysis: increase in endogenous cannabinoids in the sera of patients with endotoxic shock.Analytical biochemistry, 294 1
(2005)
downregulation of excitotoxic NMDA receptors in the ischemic penumbra. Acta Neuropathol (Berlin) 2006;112:277–286
A. Bar-Joseph, Y. Berkovitch, J. Adamchik, A. Biegon (1994)
Neuroprotective activity of HU-211, a novel NMDA antagonist, in global ischemia in gerbils.Molecular and chemical neuropathology, 23 2-3
M. Rajesh, P. Mukhopadhyay, S. Batkai, J. Huffman, A. Csiszar, Z. Ungvari, S. Chatterjee, P. Pacher (2008)
CB2 cannabinoid receptor stimulation attenuates TNF‐alpha‐induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte‐endothelial adhesion.The FASEB Journal, 22
S. Batkai, P. Mukhopadhyay, J. Harvey‐White, R. Kechrid, P. Pacher, G. Kunos (2007)
Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats.American journal of physiology. Heart and circulatory physiology, 293 3
N. Nelken, S. Coughlin, D. Gordon, J. Wilcox (1991)
Monocyte chemoattractant protein-1 in human atheromatous plaques.The Journal of clinical investigation, 88 4
A. Schecter, T. Calderon, Adriane Berman, C. Mcmanus, J. Fallon, M. Rossikhina, Weixin Zhao, G. Christ, J. Berman, M. Taubman (2000)
Human Vascular Smooth Muscle Cells Possess Functional CCR5*The Journal of Biological Chemistry, 275
S. Abi-Younes, A. Sauty, F. Mach, G. Sukhova, P. Libby, A. Luster (2000)
The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques.Circulation research, 86 2
C. Glass, J. Witztum (2001)
Atherosclerosis The Road AheadCell, 104
W. Crawford, J. Merritt (1979)
Effects of tetrahydrocannabinol on arterial and intraocular hypertension.International journal of clinical pharmacology and biopharmacy, 17 5
C. Sommer, M. Schomacher, C. Berger, Katharina Kuhnert, H. Müller, S. Schwab, W. Schäbitz (2006)
Neuroprotective cannabinoid receptor antagonist SR141716A prevents downregulation of excitotoxic NMDA receptors in the ischemic penumbraActa Neuropathologica, 112
M. Joyeux, C. Arnaud, D. Godin-Ribuot, P. Demenge, D. Lamontagne, C. Ribuot (2002)
Endocannabinoids are implicated in the infarct size-reducing effect conferred by heat stress preconditioning in isolated rat hearts.Cardiovascular research, 55 3
C. Weber (2005)
Platelets and chemokines in atherosclerosis: partners in crime.Circulation research, 96 6
P. Mukhopadhyay, S. Batkai, M. Rajesh, Nora Czifra, J. Harvey‐White, G. Haskó, Z. Zsengellér, N. Gerard, L. Liaudet, G. Kunos, P. Pacher (2007)
Pharmacological inhibition of CB1 cannabinoid receptor protects against doxorubicin-induced cardiotoxicity.Journal of the American College of Cardiology, 50 6
S. Batkai, D. Osei-Hyiaman, H. Pan, O. El-Assal, M. Rajesh, P. Mukhopadhyay, F. Hong, J. Harvey‐White, A. Jafri, G. Haskó, J. Huffman, B. Gao, G. Kunos, P. Pacher (2007)
Cannabinoid‐2 receptor mediates protection against hepatic ischemia/reperfusion injuryThe FASEB Journal, 21
F. Massa, G. Marsicano, H. Hermann, A. Cannich, K. Monory, B. Cravatt, G. Ferri, A. Sibaev, M. Storr, B. Lutz (2004)
The endogenous cannabinoid system protects against colonic inflammation.The Journal of clinical investigation, 113 8
A. Fredericks, N. Benowitz, C. Savanapridi (1981)
The cardiovascular and autonomic effects of repeated administration of delta-9-tetrahydrocannabinol to rhesus monkeys.The Journal of pharmacology and experimental therapeutics, 216 2
A. Bonz, M. Laser, Sina Küllmer, Silke Kniesch, J. Babin-Ebell, Verena Popp, G. Ertl, J. Wagner (2003)
Cannabinoids Acting on CB1 Receptors Decrease Contractile Performance in Human Atrial MuscleJournal of Cardiovascular Pharmacology, 41
N. Veillard, S. Steffens, F. Burger, G. Pelli, F. Mach (2004)
Differential Expression Patterns of Proinflammatory and Antiinflammatory Mediators During Atherogenesis in MiceArteriosclerosis, Thrombosis, and Vascular Biology, 24
G. Hansson, P. Libby (2006)
The immune response in atherosclerosis: a double-edged swordNature Reviews Immunology, 6
P. Hundelshausen, K. Weber, Yuqing Huo, A. Proudfoot, P. Nelson, K. Ley, C. Weber (2001)
RANTES Deposition by Platelets Triggers Monocyte Arrest on Inflamed and Atherosclerotic EndotheliumCirculation: Journal of the American Heart Association, 103
A. Pinto, A. Tuttolomondo, D. Raimondo, P. Fernandez, G. Licata (2004)
Cerebrovascular risk factors and clinical classification of strokes.Seminars in vascular medicine, 4 3
T. Nagayama, A. Sinor, R. Simon, Jun Chen, S. Graham, K. Jin, D. Greenberg (1999)
Cannabinoids and Neuroprotection in Global and Focal Cerebral Ischemia and in Neuronal CulturesThe Journal of Neuroscience, 19
P. Sacerdote, P. Massi, A. Panerai, D. Parolaro (2000)
In vivo and in vitro treatment with the synthetic cannabinoid CP55,940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptorsJournal of Neuroimmunology, 109
H. Wasmuth, C. Trautwein (2007)
CB1 cannabinoid receptor antagonism: A new strategy for the treatment of liver fibrosisHepatology, 45
Jie Liu, S. Batkai, P. Pacher, J. Harvey‐White, J. Wagner, B. Cravatt, B. Gao, G. Kunos (2003)
Lipopolysaccharide Induces Anandamide Synthesis in Macrophages via CD14/MAPK/Phosphoinositide 3-Kinase/NF-κB Independently of Platelet-activating Factor*Journal of Biological Chemistry, 278
C. Berger, P. Schmid, W. Schabitz, Margit Wolf, S. Schwab, H. Schmid (2004)
Massive accumulation of N‐acylethanolamines after stroke. Cell signalling in acute cerebral ischemia?Journal of Neurochemistry, 88
B. Scheuerer, M. Ernst, I. Dürrbaum-Landmann, J. Fleischer, E. Grage‐Griebenow, E. Brandt, H. Flad, F. Petersen (2000)
The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages.Blood, 95 4
Reese Jones (2002)
Cardiovascular System Effects of MarijuanaThe Journal of Clinical Pharmacology, 42
K. Coopman, L. Smith, K. Wright, S. Ward (2007)
Temporal variation in CB2R levels following T lymphocyte activation: evidence that cannabinoids modulate CXCL12-induced chemotaxis.International immunopharmacology, 7 3
P. Lépicier, J. Bouchard, C. Lagneux, D. Lamontagne (2003)
Endocannabinoids protect the rat isolated heart against ischaemiaBritish Journal of Pharmacology, 139
T. Klein, C. Newton, K. Larsen, Lily Lu, Izabella Perkins, L. Nong, H. Friedman (2003)
The cannabinoid system and immune modulationJournal of Leukocyte Biology, 74
C. Klijn, G. Hankey (2003)
Management of acute ischaemic stroke: new guidelines from the American Stroke Association and European Stroke InitiativeThe Lancet Neurology, 2
P. Katelaris, I. Salam, M. Farthing (1995)
Lactobacilli to prevent traveler's diarrhea?The New England journal of medicine, 333 20
P. Beaconsfield (1974)
Some cardiovascular effects of cannabis.American heart journal, 87 2
D. Panikashvili, C. Simeonidou, S. Ben-Shabat, L. Hanuš, A. Breuer, R. Mechoulam, E. Shohami (2001)
An endogenous cannabinoid (2-AG) is neuroprotective after brain injuryNature, 413
E. Carrier, C. Kearn, A. Barkmeier, Nicole Breese, Wenqi Yang, K. Nithipatikom, S. Pfister, W. Campbell, C. Hillard (2004)
Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism.Molecular pharmacology, 65 4
J. Wagner, K. Hu, J. Karcher, J. Bauersachs, A. Schäfer, M. Laser, Hong Han, G. Ertl (2003)
CB(1) cannabinoid receptor antagonism promotes remodeling and cannabinoid treatment prevents endothelial dysfunction and hypotension in rats with myocardial infarction.British journal of pharmacology, 138 7
S. Batkai, P. Pacher, D. Osei-Hyiaman, S. Radaeva, Jie Liu, J. Harvey‐White, László Offertáler, K. Mackie, M. Rudd, Richard Bukoski, G. Kunos (2004)
Endocannabinoids Acting at Cannabinoid-1 Receptors Regulate Cardiovascular Function in HypertensionCirculation, 110
D. Panikashvili, R. Mechoulam, S. Beni, A. Alexandrovich, E. Shohami (2005)
CB1 cannabinoid receptors are involved in neuroprotection via NF-kappa B inhibition.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 25 4
J. Bouchard, P. Lépicier, D. Lamontagne (2003)
Contribution of endocannabinoids in the endothelial protection afforded by ischemic preconditioning in the isolated rat heart.Life sciences, 72 16
Y. Nakajima, Y. Furuichi, K. Biswas, T. Hashiguchi, K. Kawahara, K. Yamaji, T. Uchimura, Y. Izumi, I. Maruyama (2006)
Endocannabinoid, anandamide in gingival tissue regulates the periodontal inflammation through NF‐κB pathway inhibitionFEBS Letters, 580
E. Formukong, A. Evans, F. Evans (1989)
The Inhibitory Effects of Cannabinoids, The Active Constituents of Cannabis sativa L. on Human and Rabbit Platelet AggregationJournal of Pharmacy and Pharmacology, 41
F. Mach (2004)
Statins as immunomodulatory agents.Circulation, 109 21 Suppl 1
A. Lusis (2000)
Atherosclerosis : Vascular biologyNature, 407
P. Pacher, S. Batkai, G. Kunos (2005)
Cardiovascular pharmacology of cannabinoids.Handbook of experimental pharmacology, 168
Atherosclerosis is a chronic inflammatory disease that is the primary cause of myocardial infarction and stroke, which occur after sudden thrombotic occlusion of an artery. A growing body of evidence suggests that cannabinoid signalling plays a fundamental role in atherosclerosis development and its clinical manifestations. Thus, CB2 receptors are protective in myocardial ischaemia/reperfusion and implicated in the modulation of chemotaxis, which is crucial for the recruitment of leukocytes during inflammation. Delta‐9‐Tetrahydrocannabinol (THC)‐mediated activation has been shown to inhibit atherosclerotic plaque progression in a CB2 dependent manner. Although CB1 and CB2 expression has been reported on platelets, their involvement in thrombus formation is still controversial. While several reports suggest that CB1 receptors may have a relevant role in neuroprotection after ischaemic stroke, recent studies show the protective effects in various forms of neuroprotection are not related to CB1 stimulation, and a protective role of CB1 blockade has also been reported. In addition, vascular and myocardial CB1 receptors contribute to the modulation of blood pressure and heart rate. It is tempting to suggest that pharmacological modulation of the endocannabinoid system is a potential novel therapeutic strategy in the treatment of atherosclerosis. For these purposes, it is important to better understand the complex mechanisms of endocannabinoid signalling and potential consequences of its pharmacological modulation, as it may have both pro‐ and anti‐atherosclerotic effects. British Journal of Pharmacology (2008) 153, 290–298; doi:10.1038/sj.bjp.0707517; published online 29 October 2007
British Journal of Pharmacology – Wiley
Published: Jan 1, 2008
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.